2021 消化系聯合學術演講年會
外賓演講（三） RECENT ADVANCES IN DIAGNOSIS AND THERAPY OF INFLAMMATORY BOWEL DISEASE Byong Duk Ye Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
With worldwide increase of its incidence and prevalence, inflammatory bowel disease (IBD) has evolved into a global burden. An improved understanding of pathophysiology and natural course of IBD has led to a significant development in the management of IBD. Advances in recent medical treatments of IBD have enabled a paradigm shift from symptomatic relief to control of inflammation for achieving disease modifications and better prognoses for patients with IBD. For optimal management of patients with IBD, the following approaches and strategies are needed to be implemented: 1) Understanding the progressive nature of IBD, especially Crohn’s disease, 2) Early diagnosis of IBD
before progression of digestive damage, 3) Proper staging of disease, 4) Prediction of disease course and individualized approach, 5) Setting appropriate therapeutic targets, 6) Earlier and timely treatment to reduce and prevent progressive digestive damage, complications and disability, 7) Proper positioning of various biologics and small molecules, 8) Tight disease monitoring using objective tools, 9) Collaboration and multidisciplinary team approach, 10) Education and engagement of patients. Consideration and application of these approaches and strategies could improve the quality of IBD care, ultimately leading to better longterm outcomes of patients with IBD.
7
